Frankfurt for 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Frankfurt for 2013


Next year will see CPhI Worldwide and its collocated events, ICSE, P-MEC and InnoPack return to Frankfurt (Germany). The event is due to take place at the Messe Frankfurt on 22–24 October so keep the dates free!

Frankfurt first hosted CPhI in 1990; indeed, it was the location of the first ever CPhI trade show, attracting 16 exhibitors and 250 delegates as a specialist event dedicated to ingredients and intermediates. Frankfurt has been a regular venue for the show ever since and last played host to CPhI in 2011. The 2011 event was a record year for the organisers with 2,200 exhibitors and around 29,920 attendees.

“We experienced a phenomenal response to the 2011 events and this has influenced our decision to return to Messe Frankfurt in 2013,” said UBM Live Pharma Portfolio Director Greg Kerwin, in a statement. “Frankfurt has traditionally been one of the most popular venues in the events’ 22 year history, not only as a result of it being located in one of Europe’s largest pharmaceutical hubs, but due to its international accessibility, quality and availability of accommodation, and the high standards of service offered by the venue.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here